We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CANB market cap is 979.01k. The company's latest EPS is USD -0.5686 and P/E is -0.07.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 669k | 2.31M | 1.71M | 4.6M | 6.69M |
| Operating Income | -3.41M | -4.58M | -4.37M | -10.27M | -14.17M |
| Net Income | -4.11M | -4.59M | -5.72M | -12.17M | -14.92M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 3.69M | 6.93M | 5.69M | 16.48M | 15.56M |
| Total Liabilities | 205k | 565k | 2.44M | 10.86M | 12.86M |
| Total Equity | 3.49M | 6.37M | 3.26M | 5.62M | 2.7M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -754k | -2.41M | -1.95M | -7.32M | -8.89M |
| Investing | -46k | -1.66M | -25k | -860k | N/A |
| Financing | 1.61M | 3.31M | 2.38M | 8.17M | 3.57M |
| Market Cap | 979.01k |
| Price to Earnings Ratio | -0.07 |
| Price to Sales Ratio | 0.16 |
| Price to Cash Ratio | 14.29 |
| Price to Book Ratio | 0.39 |
| Dividend Yield | - |
| Shares Outstanding | 26.25M |
| Average Volume (1 week) | 16.27k |
| Average Volume (1 Month) | 558.87k |
| 52 Week Change | -94.59% |
| 52 Week High | 0.8899 |
| 52 Week Low | 0.01195 |
| Spread (Intraday) | 0.01 (29.22%) |
| Company Name | CAN B Corporation (QB) |
| Address |
5686 bayview dr seminole, florida 33772 |
| Website | https://www.canbiola.com |
| Industry | drugs and proprietary-whsl (5122) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
